发明名称 METHODS FOR MODULATING KALLIKREIN (KLKB1) EXPRESSION
摘要 <p>Disclosed herein are methods for decreasing kallikrein and treating, preventing, or ameliorating metabolic conditions in an individual in need thereof. Examples of disease conditions that can be treated, prevented, or ameliorated with the administration of antisense compounds targeted to kallikrein include obesity and diabetes. Methods for inhibiting kallikrein can also be used as a prophylactic treatment to prevent individuals at risk for developing a metabolic condition.</p>
申请公布号 WO2013188876(A3) 申请公布日期 2015.06.25
申请号 WO2013US46147 申请日期 2013.06.17
申请人 JOSLIN DIABETES CENTER, INC. 发明人 FEENER, EDWARD;CLERMONT, ALLEN
分类号 A61K31/70 主分类号 A61K31/70
代理机构 代理人
主权项
地址